Filing Details
- Accession Number:
- 0001193805-17-003451
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-13 13:46:54
- Reporting Period:
- 2017-11-09
- Accepted Time:
- 2017-11-13 13:46:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1368514 | Adma Biologics Inc. | ADMA | Biological Products, (No Disgnostic Substances) (2836) | 562590442 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1542517 | S Adam Grossman | C/O Adma Biologics, Inc. 465 State Route 17 Ramsey NJ 07446 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-11-09 | 485,000 | $2.15 | 744,000 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
Footnotes
- Represents a purchase from the underwriters in the Issuer's public offering.
- These shares are owned by Areth, LLC ("Areth"). The reporting person is a control person of Areth.